Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 18 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

28%

5 trials in Phase 3/4

Results Transparency

19%

3 of 16 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

15Total
Not Applicable (5)
P 1 (2)
P 2 (3)
P 3 (3)
P 4 (2)

Trial Status

Completed16
Unknown1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 16 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07307989Phase 2Recruiting

Early Statin-Ezetimibe Combination vs. Statin Monotherapy in Stroke With Atherosclerosis

NCT03634436Phase 1CompletedPrimary

The PK/PD Study of A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects

NCT05164185Not ApplicableCompletedPrimary

The Effect of Remote Ischemic Conditioning in Patients With Hypercholesterolemia

NCT02850224Not ApplicableCompleted

Pediatric Preventative Health Screenings - Obesity and Family-Centered Outcomes

NCT02634151Phase 2CompletedPrimary

A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins

NCT02722408Phase 2CompletedPrimary

Efficacy and Safety of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid-Lowering Therapy (COBALT-1)

NCT02587416Phase 1CompletedPrimary

Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers

NCT00376584Phase 3CompletedPrimary

Effect of an Investigational Compound on Tolerability of Extended Release Niacin (0524A-023)(COMPLETED)

NCT00153738Not ApplicableCompletedPrimary

Phytosterol Supplementation and Cardiovascular Risk

NCT01890889Not ApplicableUnknown

Study of Changes in Total Cholesterol Levels as a Function of Consuming a Supplement Designed to Improve Cardiovascular Health

NCT01477944CompletedPrimary

Pattern of Statins Use in Catalonia

NCT00408382Phase 4CompletedPrimary

Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

NCT00329160Phase 4CompletedPrimary

Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease

NCT00347217CompletedPrimary

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

NCT01354327Not ApplicableCompletedPrimary

Effects of Limicol on LDL-cholesterol

NCT00225589Phase 3CompletedPrimary

A Study Measuring Effects on Intima Media Thickness: An Evaluation of Rosuvastatin 40 mg (METEOR)

NCT00239330Phase 3CompletedPrimary

Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy

NCT00688454CompletedPrimary

C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients

Showing all 18 trials

Research Network

Activity Timeline